Classifying cancer-associated fibroblasts—The good, the bad, and the target

2024-9-1

Ovarian cancer metastasis: Looking beyond the surface

2024-9-1

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

2024-9-1

Integrated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma

2024-9-1

Assessing clonal changes in T cells over time following immunotherapy is a breeze with Cyclone

2024-9-1

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer

2024-9-1

Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain

2024-9-1

From backstage to the spotlight: γδT cells in cancer

2024-9-1

Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence

2024-9-1

Glioblastoma induces the recruitment and differentiation of dendritic-like “hybrid” neutrophils from skull bone marrow

2024-9-1

Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial

2024-8-1

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer

2024-8-1

Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

2024-8-1

When playing the NK cell therapy card in glioblastoma, you can’t beat interleukin-21

2024-8-1

The KRAS mutational spectrum and its clinical implications in pancreatic cancer

2024-8-1

Precision oncology across the ages: Impact on children, adolescents, and young adults

2024-8-1

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD

2024-8-1

Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer

2024-8-1

Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors

2024-8-1

Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer

2024-8-1

Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study

2024-8-1

Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells

2024-8-1

Leading medulloblastoma to a differentiation end

2024-8-1

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells

2024-8-1

Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

2024-8-1

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers

2024-8-1

CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis

2024-8-1

Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma

2024-8-1

Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers

2024-8-1

PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancer

2024-8-1

CAR T cell combination therapies to treat cancer

2024-7-25

Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity

2024-7-18

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

2024-7-1

Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures

2024-7-1

HRS-4642: The next piece of the puzzle to keep KRAS in check

2024-7-1

Perilymphatic regulatory T cell-dendritic cell interactions represent a novel axis of immunosuppression in cancer

2024-7-1

Casting a wider net: The clinical potential of EV transcriptomics in multi-analyte liquid biopsy

2024-7-1

Immune cell triads reprogram exhausted CD8+ T cells for effective tumor elimination

2024-7-1

Multi-scale signaling and tumor evolution in high-grade gliomas

2024-7-1

Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors

2024-7-1

How can we integrate the biology of breast cancer cell dormancy into clinical practice?

2024-7-1

Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors

2024-7-1

Bacteria in metastatic sites: Unveiling hidden players in cancer progression

2024-7-1

Transcription factor dependencies identify BAF-dependent cancers

2024-7-1

Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer

2024-7-1

Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial

2024-7-1

Tumor-infiltrating lymphocytes: A new hope

2024-7-1

Medulloblastoma subgrouping at first sight

2024-7-1

Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer

2024-7-1

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution

2024-7-1